NASDAQ:FCSC - Fibrocell Science, Inc.
$2.24
 $-0.02
-0.88%
4:00PM EDT
2019-04-18
Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related. It is investigating the indication in a Phase II clinical trial. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. Its product, LAVIV (azficel-T), is indicated for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. A third gene-therapy program is focused on the treatment of arthritis. Its product, LAVIV (azficel-T), is focused on improving the appearance of nasolabial fold wrinkles in adults. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  FCSC     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 32   203. 85   241. 91  
42 stocks rank:  4. 04 K 1. 44 K 1. 05 K
# analyst opinions:  2. 00   14. 51   13. 97  

quick ratio:  6. 64   5. 27   1. 81  
current ratio:  6. 69   5. 62   2. 25  

target price low:  3. 18   84. 80   115. 21  
target price avg:  1. 60   111. 51   137. 51  
target price high:  2. 20   135. 81   157. 84  
1-yr high:  4. 80   114. 23   138. 78  
last close:  2. 24   87. 66   116. 69  
50-day avg:  2. 06   95. 54   123. 44  
200-day avg:  2. 05   94. 25   121. 11  
1-yr low:  1. 50   72. 78   98. 34  
volume:  1. 14 M 4. 11 M 8. 07 M
50-day avg volume:  1. 17 M 2. 76 M 5. 02 M
200-day avg volume:  417. 06 K 2. 92 M 4. 59 M

1-day return:  -0. 88 % -0. 41 % 0. 07 %
this week return:  25. 84 % -5. 74 % -4. 11 %
12-wk return:  16. 67 % 1. 61 % -0. 05 %
52-wk return:  -23. 39 % 3. 12 % 8. 78 %

enterprise value (EV):  7. 43 M 48. 94 B 114. 64 B
market cap:  21. 86 M 43. 07 B 104. 73 B
EBITDA:  -12. 00 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -0. 62   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -11. 13 M 2. 20 B 4. 20 B

shares outstanding:  9. 76 M 571. 70 M 1. 24 B
shares:  7. 12 M 571. 81 M 1. 23 B
shares short:  1. 02 M 10. 17 M 13. 00 M
shares short prior month:  1. 00 M 9. 54 M 17. 33 M
short ratio:  1. 64   5. 41   3. 28  
total cash/share:  1. 48   11. 14   9. 33  
total cash:  14. 43 M 6. 71 B 7. 15 B
free cash flow:  -9. 34 M 3. 58 B 2. 96 B
operating cash flow:  -12. 72 M 4. 15 B 4. 30 B

book value:  0. 98   12. 78   26. 92  
price/book:  2. 29   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  60. 00 % --- ---
1-yr mean volatility:  0. 08 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 45   2. 40   4. 10  
forward EPS:  -1. 03   3. 97   7. 13  
P/E:  -1. 54   13. 63   22. 72  
forward P/E:  -2. 17   -15. 95   13. 99  
PE/G:  0. 05   -1. 65   -1. 32  
growth:  -32. 08 % 127. 12 % 29. 61 %
earnings high:  -0. 33   1. 00   1. 66  
earnings avg:  -0. 35   0. 77   1. 53  
earnings low:  -0. 37   0. 50   1. 39  
revenue high:  100. 00 K 2. 68 B 10. 78 B
revenue avg:  50. 00 K 2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -44. 03 % -2. 75 % 4. 55 %
return on equity:  -110. 72 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  0. 57   1. 25   0. 93  
sharpe (1yr):  0. 19   0. 37   0. 70  

held % insiders:  0. 17 % 6. 39 % 3. 38 %
held % institutions:  27. 83 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : FCSC
.    + 0.047 =         0.047 :: INITIAL WEIGHT
.   + 27.066 =        27.112 :: spline projection addition
.    x 1.431 =        38.809 :: industry recommendation factor
.    x 0.996 =        38.638 :: return on assets factor
.    x 0.989 =        38.211 :: return on equity factor
.     x 2.81 =       107.377 :: current ratio factor
.    x 1.085 =       116.502 :: quick ratio factor
.    x 1.269 =       147.813 :: short ratio factor
.    x 2.023 =       299.009 :: price-to-book factor
.    x 1.077 =       322.101 :: 5-day avg > 200-day avg
.    x 1.073 =       345.466 :: 5-day avg > 50-day avg
.    x 1.004 =       346.976 :: 50-day avg > 200-day avg
.    x 2.151 =       746.343 :: P/E weight
.    x 2.135 =      1593.279 :: PE/G factor
.    x 1.536 =      2446.848 :: beta factor
.    x 0.185 =       453.184 :: sharpe factor
.    x 1.691 =       766.149 :: target low factor
.    x 0.905 =       693.563 :: target mean factor
.    x 0.987 =       684.295 :: target high factor
.     x 1.31 =       896.349 :: industry 2-weeks return factor
.     x 0.88 =        788.63 :: "drift" penalty 1 days ago
.    x 0.625 =       493.009 :: "drift" penalty 2 days ago
.    x 0.818 =       403.265 :: "drift" penalty 3 days ago
.      x 0.4 =       161.306 :: largest single-day jump factor
.    x 0.067 =        10.797 :: low price factor
.      x 1.0 =        10.795 :: factor hist industry gain for week 16
.   cubeRoot =          2.21 :: reduced to standardize
.   - 23.402 =         0.324 :: add/subtract for performance
.                      0.324 :: FINAL WEIGHT for NASDAQ:FCSC


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org